The Geographic Distribution of Pediatric Anesthesiologists Relative to the US Pediatric Population

Matthew K Muffly1, David Medeiros, Tyler M Muffly

  • 1From the *Stanford University Medical Center, Stanford, California; †Stanford University Geospatial Center, Stanford, California; and ‡Denver Health Medical Center, Denver, Colorado.

Anesthesia and Analgesia
|December 17, 2016
PubMed

Insights

Millions of US children lack proximity to pediatric anesthesiologists, impacting access to specialized care. Geographic disparities highlight the need for improved distribution of these essential medical professionals.

Area of Science:

  • Anesthesiology
  • Pediatrics
  • Health Services Research
  • Geographic Information Systems (GIS)

Background:

  • Geographic distribution of pediatric anesthesiologists is crucial for clinical care and policy.
  • Understanding this distribution relative to the pediatric population is essential.

Purpose of the Study:

  • To map and analyze the geographic distribution of pediatric anesthesiologists in the US.
  • To assess the proximity of the pediatric population (0-17 years and 0-4 years) to these specialists.

Main Methods:

  • Utilized GIS to create driving distance service areas around pediatric anesthesiologist locations.
  • Employed US Census block groups to calculate pediatric population density within these areas.
  • Determined pediatric anesthesiologist-to-pediatric population ratios across 306 Hospital Referral Regions (HRRs).

Main Results:

  • 71.4% of children live within a 25-mile drive of a pediatric anesthesiologist.
  • Over 10.2 million children (0-17 years) and 2.7 million young children (0-4 years) reside more than 50 miles away.
  • Pediatric anesthesiologist distribution is less uniform and lower compared to other physician groups.

Conclusions:

  • A significant portion of the US pediatric population faces geographic barriers to accessing pediatric anesthesiologists.
  • Wide variations in HRR-level ratios suggest unequal access to care.
  • Findings are critical given new guidelines mandating pediatric anesthesiologist involvement in pediatric surgery verification.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
407
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
637
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
898
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306